Browse diseases

… long-term respiratory conditions.Method We screened paediatric bronchiectasis patients using the Strengths & Difficulties Questionnaire (SDQ)…

… Aspergillus-specific IgE titres >0.35 kUA/L, 24.5% vs 3.8%) in eosinophilic bronchiectasis. Sputum inflammatory biomarkers and clinical parameters did not…

…Background Pulmonary non-tuberculous mycobacterial (NTM) disease is a respiratory infection with an increasing incidence worldwi…

…solation approach to identify therapeutically viable phages for bronchiectasis patients.…

… and GORD.Conclusions We found that multimorbidity is common in bronchiectasis and is significantly associated with a poorer HRQoL, more frequ…

…n and therapeutic individualisation.3 4 In contrast, paediatric bronchiectasis has remained largely without validated clinical phenotypes capa…

…Introduction Patients with bronchiectasis unrelated to cystic fibrosis (CF) present variability in daily symptoms. Recurrent episodes …

…l of 36 patients were initiated on HTS, of which 42% (n=15) had Bronchiectasis, 8% (n=3) had COPD, 22% had Asthma (n=8), 11% had Asthma-COPD o…

…pping azithromycin therapy in patients with non-cystic fibrosis bronchiectasis. The SWAT was developed to reduce disparities in patient partic…

…es are genetically diverse, comparable to global collections of bronchiectasis isolates. In a rooted phylogenetic tree, 163 patient-specific c…

…(3) bronchial artery embolisation can be lifesaving in cases of nocardial vasculitis with active bleeding. The report underscores the importance of …

…h as M. porcinum, M. fortuitum, and M. malmoense.COPD (44%) and bronchiectasis (23%) were the most common comorbidities, but notably, 17% of p…